[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

US824539A - Process of making an internal remedy. - Google Patents

Process of making an internal remedy. Download PDF

Info

Publication number
US824539A
US824539A US26225305A US1905262253A US824539A US 824539 A US824539 A US 824539A US 26225305 A US26225305 A US 26225305A US 1905262253 A US1905262253 A US 1905262253A US 824539 A US824539 A US 824539A
Authority
US
United States
Prior art keywords
internal
making
remedy
compound
sulfonic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US26225305A
Inventor
Richard Griese
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US26225305A priority Critical patent/US824539A/en
Application granted granted Critical
Publication of US824539A publication Critical patent/US824539A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14Radicals substituted by oxygen atoms

Definitions

  • the subject-matter of the present invention relates to a process for preparing in a condition which renders possible its internal application the complicated organic iodin compound metaiodinorthooxyquinolin sulfonic acid, (O ILIOHSO HNQ covered by the United States'Patent No. 57 6,494.
  • the present invention also relates to medicaments or internal disinfectants containing this compound.
  • the sodium bicarbonate is mixed with the peppermint-oil until the whole quantity of the said sodium compound mixes uniformly with the oil, which has been added in drops, or until the latter has dissolved in the former substance.
  • the metaiodinorthooxyquinolin-sulfonic acid is then added and thoroughlyincorporatedtherewith,preferably by stirring and sifting.
  • the mixture thus resulting which is in the form of powder, is most suitably introduced into the wellknown capsules, which readily dissolve in the mouth.
  • the compounding of the product is de pendent, according to the requirements to be determined in each case by the physician, not only upon variations within the above-stated limits, but also under some circumstances several constituents appear to be dispensable-for example, the addition of tannalbin in all cases where the patient is not inclined to diarrhea.
  • the powder produced according to the process described has proved itself to be a medimecant or internal disinfectant free from the unpleasant taste of metaiodinorthooxyquinolin-sulfonic acid and the frequently loosening effect on the bowels of that iodin compound, which in itself remains undissolved in the stomach, is opposed by a kind of bindin action, in consequence of the tannalbin.
  • the said powder is also readily soluble in water, in case of need it can be employed also for injections under the skin, in which case it exercises a more violent bacteria-killing action.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Description

UNITED STATES PATENT OFFICE.
PROCESS OF MAKING AN INTERNAL REMEDY.
Specification of Letters Patent.
Patented June 26, 1906.
- Application filed May 25,1905. Serial No. 262,253-
To all whom it may concern;
Be it known that I, RICHARD GRIEsE, chemist, a subject of the King of Prussia, German Emperor, residing at Berlin, Kingdom of Prussia, in the Empire of Germany, have invented a new and useful Process of Making an Internal Remedy, of which the following is a specification.
The subject-matter of the present invention relates to a process for preparing in a condition which renders possible its internal application the complicated organic iodin compound metaiodinorthooxyquinolin sulfonic acid, (O ILIOHSO HNQ covered by the United States'Patent No. 57 6,494.
The present invention also relates to medicaments or internal disinfectants containing this compound.
Hitherto the said organic iodin compound has been utilized in medicine only for external treatment, the internal treatment having been hitherto deemed out of the question on account of the damage to the stomach connected with such an internal application and on account of disturbances produced in the circulation of the blood. In order to render possible the internal application of the said iodin compound, which is very useful in itself, it is first and foremost necessary to bring the same into a readily-soluble condition, so that the compound on being taken is readily incorporated in the gastric juices or the blood. With this object in view a quantity of sodium bicarbonate, oleum menthae piperitae, (peppermint-0H,) and, if desired, tannalbin (which consists of tannic acid and albumin) are added in certain proportions. The quantity of metaiodinorthooxyquinolinsulfonic acid, according to the exigencies of the case to be treated, varies between nine hundred and twenty-five and four hundred grams per one thousand grams of the mixture, and the amount of sodium bicarbonate between seventy-five and six hundred grams, whereas the oleum menthae piperitae is added only by drops, and when needed tannalbin is added to the extent of twenty-five grams per one thousand grams of the mixture.
The sodium bicarbonate is mixed with the peppermint-oil until the whole quantity of the said sodium compound mixes uniformly with the oil, which has been added in drops, or until the latter has dissolved in the former substance. To this sodium bicarbonate containing peppermint-oil the metaiodinorthooxyquinolin-sulfonic acid is then added and thoroughlyincorporatedtherewith,preferably by stirring and sifting. The mixture thus resulting, which is in the form of powder, is most suitably introduced into the wellknown capsules, which readily dissolve in the mouth.
The compounding of the product is de pendent, according to the requirements to be determined in each case by the physician, not only upon variations within the above-stated limits, but also under some circumstances several constituents appear to be dispensable-for example, the addition of tannalbin in all cases where the patient is not inclined to diarrhea.
Experiment has shown that the addition of sodium bicarbonate effects the desired easy solubility of the metaiodinorthoxyquinolin-sulfonic acid in the gastric juice, improves the appetite during use, and in particular causes animprovement in the progress of digestion, which has a beneficial effect on the general state of health of the patient.
The powder produced according to the process described has proved itself to be a medimecant or internal disinfectant free from the unpleasant taste of metaiodinorthooxyquinolin-sulfonic acid and the frequently loosening effect on the bowels of that iodin compound, which in itself remains undissolved in the stomach, is opposed by a kind of bindin action, in consequence of the tannalbin. s the said powder is also readily soluble in water, in case of need it can be employed also for injections under the skin, in which case it exercises a more violent bacteria-killing action.
What I claim as my invention, and desire to secure by Letters Patent, is
The herein-described process of producing from metaiodinorthooxyquinolin sulfonic acid an internal remedy capable of being assimilated and carried into the blood circulation which consists in mixing bicarbonate of soda with a small proportion of oil of peppermint, and incorporating said mixture with metaiodinorthooxyquinolin-sulfonic acid.
In testimony whereof I have signed my name to this specification in the-presence of two subscribing witnesses.
RICHARD GRIESE.
Witnesses:
WOLDEMAR HAUPT, HENRY HASPER.
US26225305A 1905-05-25 1905-05-25 Process of making an internal remedy. Expired - Lifetime US824539A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US26225305A US824539A (en) 1905-05-25 1905-05-25 Process of making an internal remedy.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26225305A US824539A (en) 1905-05-25 1905-05-25 Process of making an internal remedy.

Publications (1)

Publication Number Publication Date
US824539A true US824539A (en) 1906-06-26

Family

ID=2893019

Family Applications (1)

Application Number Title Priority Date Filing Date
US26225305A Expired - Lifetime US824539A (en) 1905-05-25 1905-05-25 Process of making an internal remedy.

Country Status (1)

Country Link
US (1) US824539A (en)

Similar Documents

Publication Publication Date Title
JP3255641B2 (en) Orally administered pharmaceutical composition used as gastrointestinal detergent or laxative
CN1105561A (en) Thrapeutic composition and method of using same for treatment of hangover
DE3319575C2 (en)
CA2974843C (en) Compositions containing arsenic and their use in methods of treatment
US944738A (en) Medicament for diseases of the mucous membrane.
US824539A (en) Process of making an internal remedy.
WO1991015200A2 (en) Use of trinitrobenzenes or carminic acid in the treatment of cancer or viral diseases
CN1060336C (en) Medicine for prevention and treatment of calcium deficiency and its prepn
JP2769587B2 (en) Powder nutrition composition
US6686392B1 (en) Lipidic zinc compounds and use for treatment of prostatic hypertrophy
US2138546A (en) Therapeutic preparation of colloidal sulphur
US3076747A (en) Pharmaceutical iron preparations
RU2629338C1 (en) Pharmaceutical composition for homeostasis stabilization and pathological processes arresting in organism, and injection dosage form of this composition
US473331A (en) Andrew davidson mckay
Breidenbach et al. A quantitative in vitro study of antacids
US2034783A (en) Process of making a therapeutic composition
US4649152A (en) Composition and method for treatment of potassium deficiency
US379300A (en) Solution of quinine
US695254A (en) Pancreas preparation and process of producing same.
US237058A (en) Hog-cholera compound
US1129270A (en) Medicinal preparation for human use.
US4029771A (en) Composition for the treatment of bacterial-intestinal infections
US152327A (en) Improvement in medical compounds
US138282A (en) Improvement in medical compounds called milk of magnesia
KR100966219B1 (en) Method For Producing Pharmaceutical Preparation Containing Methylmethioninesulfonium Chloride